Menu
PhRMA President and CEO Stephen Ubl touts the drug industry's efforts to comply with Trump administration drug pricing initiatives in a recent video posted on Americasmedicines.com.
PhRMA President and CEO Stephen Ubl took issue with efforts to codify the White House's "MFN" deals. He previously discussed PhRMA's efforts to lower drug prices in a 2025 video posted on Americasmedicines.com.

PhRMA Leader Again Hits Back Against Trump’s MFN Codification Plan, Pushes PBM and 340B Reform Instead

Shannon Young, Associate Editor/Senior Writer 340B Report Views
An influential drug industry trade group has once again taken aim at federal health officials’ efforts to codify President Donald [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

AEH Policy Paper Calls For 340B Contract Pharmacy Protections, Continued Up-Front Discounts 

Key Takeaways from the 2026 340B Winter Coalition Conference

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live